The global molecular biology enzymes market was valued at USD 15.7 billion in 2022, growing at a CAGR of 14.5% from 2023 to 2032. The market is expected to reach USD 60.8 billion by 2032. The growing prevalence of genetic disorders and infectious diseases, the life science industry's increased R&D activity, and the rapid improvement of technology are the factors driving the market's expansion.
El contenido subido será trasladado a este nuevo álbum. Debes crear una cuenta o entrar si quieres editar este álbum más adelante.